Jeffrey Meyerhardt — Boston, Massachusetts

Jeffrey Meyerhardt is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Jeffrey Meyerhardt has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Cancer, Adenocarcinoma.

Sponsors: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Jeffrey Meyerhardt?

Jeffrey Meyerhardt has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Jeffrey Meyerhardt conducted?

Jeffrey Meyerhardt has 1 clinical trials on record. Their work covers Pancreatic Cancer, Adenocarcinoma.

Is Jeffrey Meyerhardt accredited by Crixeo Health?

Jeffrey Meyerhardt has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Jeffrey Meyerhardt?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.